Paving the way to better care

A public-private international research collaboration aiming to personalise prevention and treatment of cardiovascular disease.

What moves us

The challenge of cardiovascular disease

Cardiovascular disease (CVD) is a highly prevalent disease that poses challenges to healthcare systems worldwide. In Europe alone, it affects over 85 million people – a number that is rising due to an aging population and unhealthy lifestyles.

Despite medical advancements, treating CVD effectively remains challenging due to the complex interplay of risk factors and co-existing conditions in patients, such as diabetes and hypertension.

While a “one size fits all” approach persists, the diverse nature of CVD calls for personalized treatment strategies that improve care for patients. That’s the ultimate goal of iCARE4CVD.

Number of people affected by CVD

> 500 million worldwide

Number of people that die from CVD

~ 17 million worldwide

iCARE4CVD approach

From one-size-fits-all to personalised care

By creating one database gathering data from more than 1 million patients and using artificial intelligence, iCARE4CVD will look for new strategies to shift from a one-size-fits-all approach to personalised care.

The project will focus on improving four key areas of current CVD healthcare by:

Enhancing early diagnosis of patients at risk with cardiovascular disease
Developing and assign risk levels to patients, defining those who need urgent intervention
Predict how individuals will respond to treatment through the application of AI-based tools
Ensure the inclusion of patient-supported outcomes by incorporating their unique perspectives into every area of our work

38 leading partners

from civil society, academia, and industry

22 million EUR

in funding

4.5 years

of project duration

Play Video

Get updated

Our latest news

15 January, 2026

CMEO: making heart disease and clinical studies easier to find, compare, and reuse

Across Europe, vast amounts of heart disease data already exist—but they are..

15 January, 2026

Beyond medical results: Using Patient-Reported Outcomes and Experiences in heart care – a scoping review

In a recent scoping review, we examined 390 studies to understand how..

2 January, 2026

iCARE4CVD salutes the new EU cardiovascular Health Plan!

With the new EU Cardiovascular Health Plan launched – iCARE4CVD welcomes the..

iCARE4CVD partners

iCARE4CVD brings together 38 leading international partners from civil society, academia and industry, and is lead by Maastricht University and global
healthcare company Novo Nordisk.